bupropion has been researched along with tetrabenazine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cooper, BR; Howard, JL; Soroko, FE | 1 |
| Maxwell, RA; Soroko, FE | 1 |
| Ferris, RM; Hollingsworth, EB; Kenney, BT; Mehta, NB; Musso, DL; Soroko, FE | 1 |
| Baqi, Y; Correa, M; Freeland, C; Hart, EE; López-Cruz, L; Müller, CE; Nunes, EJ; Randall, PA; Salamone, JD; Yohn, SE | 1 |
| Baqi, Y; Correa, M; Khan, B; Lee, CA; Makriyannis, A; Müller, CE; Nowak, V; Nunes, EJ; Pandit, S; Randall, PA; Salamone, JD; Shah, P; Vemuri, VK; Yohn, SE | 1 |
| Baqi, Y; Correa, M; Lee, CA; Müller, CE; Randall, PA; Salamone, JD; Thompson, C; Yohn, SE | 1 |
| Collins, SL; Contreras-Mora, HM; Correa, M; Errante, EL; Rowland, MA; Salamone, JD; Yohn, SE | 1 |
| Carratalá-Ros, C; Correa, M; Martínez-Verdú, A; Olivares-García, R; Salamone, JD | 1 |
1 review(s) available for bupropion and tetrabenazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 other study(ies) available for bupropion and tetrabenazine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Animal models used in prediction of antidepressant effects in man.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Depressive Disorder; Drug Evaluation, Preclinical; Drug Synergism; Helplessness, Learned; Humans; Levodopa; Mice; Models, Biological; Motor Activity; Propiophenones; Rats; Reserpine; Tetrabenazine | 1983 |
The pharmacologic basis for therapeutic interest in bupropion.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Blood Pressure; Brain Chemistry; Bupropion; Conditioning, Operant; Depressive Disorder; Dogs; Drug Evaluation, Preclinical; Guinea Pigs; Heart Rate; Humans; Mice; Models, Biological; Motor Activity; Propiophenones; Rats; Sleep; Tetrabenazine | 1983 |
Synthesis and evaluation of the antidepressant activity of the enantiomers of bupropion.
Topics: Animals; Biogenic Amines; Bupropion; Corpus Striatum; Dopamine; Hypothalamus; Indicators and Reagents; Male; Mice; Mice, Inbred Strains; Norepinephrine; Serotonin; Stereoisomerism; Structure-Activity Relationship; Synaptosomes; Tetrabenazine | 1993 |
Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression.
Topics: Adenosine A2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Bupropion; Conditioning, Operant; Depression; Disease Models, Animal; Dopamine; Dopamine and cAMP-Regulated Phosphoprotein 32; Enkephalins; Feeding Behavior; Immunohistochemistry; Male; Microdialysis; Motivation; Nucleus Accumbens; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Substance P; Tetrabenazine; Vesicular Monoamine Transport Proteins; Xanthines | 2013 |
The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice task: reversal with antidepressant drugs.
Topics: Animals; Antidepressive Agents; Benzazepines; Benzophenones; Bupropion; Cannabinoid Receptor Antagonists; Choice Behavior; Depression; Dopamine Antagonists; Drug Evaluation, Preclinical; Feeding Behavior; Male; Nitrophenols; Pyrazoles; Rats, Sprague-Dawley; Salicylamides; Selegiline; Tetrabenazine; Tolcapone; Vesicular Monoamine Transport Proteins; Xanthines | 2014 |
The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion.
Topics: Adenosine A2 Receptor Antagonists; Animals; Antidepressive Agents; Bupropion; Catecholamines; Choice Behavior; Decision Making; Dopamine Antagonists; Dose-Response Relationship, Drug; Male; Maze Learning; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Tetrabenazine; Vesicular Monoamine Transport Proteins; Xanthines | 2015 |
Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior.
Topics: Animals; Antidepressive Agents; Benzazepines; Bupropion; Choice Behavior; Desipramine; Dopamine Antagonists; Dose-Response Relationship, Drug; Fluoxetine; Haloperidol; Male; Motivation; Neurotransmitter Uptake Inhibitors; Piperazines; Rats, Sprague-Dawley; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2016 |
Effects of the dopamine depleting agent tetrabenazine in tests evaluating different components of depressive-like behavior in mice: sex-dependent response to antidepressant drugs with SERT and DAT blocker profiles.
Topics: Animals; Antidepressive Agents; Bupropion; Dopamine; Female; Fluoxetine; Humans; Male; Mice; Sucrose; Tetrabenazine | 2023 |